Pharmacologic activation of delta133p53α reduces cellular senescence in progeria patients-derived cells

Sebastien M. Joruiz, Delphine Lissa, Natalia Von Muhlinen, Patricia K. Dranchak, James Inglese, Izumi Horikawa, Curtis C. Harris

Open source

DOI
10.31491/apt.2025.09.185
Published
2025-09-25
Container
Aging Pathobiology and Therapeutics
Publisher
Ant Publishing
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.31491/apt.2025.09.185,
  title = {Pharmacologic activation of delta133p53α reduces cellular senescence in progeria patients-derived cells},
  author = {Sebastien M. Joruiz and Delphine Lissa and Natalia Von Muhlinen and Patricia K. Dranchak and James Inglese and Izumi Horikawa and Curtis C. Harris},
  year = {2025},
  journal = {Aging Pathobiology and Therapeutics},
  doi = {10.31491/apt.2025.09.185},
  url = {https://doi.org/10.31491/apt.2025.09.185}
}

RIS

TY  - JOUR
TI  - Pharmacologic activation of delta133p53α reduces cellular senescence in progeria patients-derived cells
AU  - Sebastien M. Joruiz
AU  - Delphine Lissa
AU  - Natalia Von Muhlinen
AU  - Patricia K. Dranchak
AU  - James Inglese
AU  - Izumi Horikawa
AU  - Curtis C. Harris
PY  - 2025
JO  - Aging Pathobiology and Therapeutics
DO  - 10.31491/apt.2025.09.185
UR  - https://doi.org/10.31491/apt.2025.09.185
ER  - 

APA

Joruiz, S. M., Lissa, D., Muhlinen, N. V., Dranchak, P. K., Inglese, J., Horikawa, I., & Harris, C. C. (2025). Pharmacologic activation of delta133p53α reduces cellular senescence in progeria patients-derived cells. Aging Pathobiology and Therapeutics. https://doi.org/10.31491/apt.2025.09.185

Source records